Reiko Yamada

1.7k total citations
47 papers, 1.3k citations indexed

About

Reiko Yamada is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Reiko Yamada has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Molecular Biology. Recurrent topics in Reiko Yamada's work include Monoclonal and Polyclonal Antibodies Research (15 papers), Lymphoma Diagnosis and Treatment (12 papers) and Immunotherapy and Immune Responses (11 papers). Reiko Yamada is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (15 papers), Lymphoma Diagnosis and Treatment (12 papers) and Immunotherapy and Immune Responses (11 papers). Reiko Yamada collaborates with scholars based in United States, Japan and Netherlands. Reiko Yamada's co-authors include John M. Timmerman, David J. Betting, David Andorsky, Jonathan Said, Geraldine S. Pinkus, Ronald G. Crystal, Shinpei Katou, Miki Yoshioka, Nobuaki Ishihama and Hirofumi Yoshioka and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Plant Cell.

In The Last Decade

Reiko Yamada

45 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reiko Yamada United States 17 695 569 351 322 202 47 1.3k
Masaki Ito Japan 19 573 0.8× 351 0.6× 761 2.2× 173 0.5× 28 0.1× 38 1.3k
Yulius Y. Setiady United States 18 293 0.4× 428 0.8× 427 1.2× 49 0.2× 91 0.5× 35 1.1k
Bianca von Scheidt Australia 16 918 1.3× 938 1.6× 215 0.6× 77 0.2× 38 0.2× 21 1.3k
Mercedes Gallardo Spain 13 500 0.7× 248 0.4× 1.1k 3.0× 95 0.3× 54 0.3× 14 1.7k
Jason M. Redman United States 16 571 0.8× 583 1.0× 284 0.8× 33 0.1× 54 0.3× 53 1.0k
David Siwarski United States 17 442 0.6× 397 0.7× 602 1.7× 155 0.5× 16 0.1× 41 1.1k
Shobha Seetharam United States 10 557 0.8× 739 1.3× 488 1.4× 40 0.1× 35 0.2× 20 1.3k
Bart Steiner United States 10 203 0.3× 311 0.5× 518 1.5× 322 1.0× 47 0.2× 17 1.0k
Ming Wei France 19 574 0.8× 313 0.6× 574 1.6× 81 0.3× 29 0.1× 51 1.3k
Mala Mani United States 11 413 0.6× 132 0.2× 1.1k 3.1× 113 0.4× 68 0.3× 15 1.4k

Countries citing papers authored by Reiko Yamada

Since Specialization
Citations

This map shows the geographic impact of Reiko Yamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reiko Yamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reiko Yamada more than expected).

Fields of papers citing papers by Reiko Yamada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reiko Yamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reiko Yamada. The network helps show where Reiko Yamada may publish in the future.

Co-authorship network of co-authors of Reiko Yamada

This figure shows the co-authorship network connecting the top 25 collaborators of Reiko Yamada. A scholar is included among the top collaborators of Reiko Yamada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reiko Yamada. Reiko Yamada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hamada, Yasuhiko, Kyosuke Tanaka, Masaki Katsurahara, et al.. (2023). Factors Related to Difficulty in Endoscopic Submucosal Dissection for Superficial Esophageal Cancer. Digestive Diseases. 41(4). 543–552. 4 indexed citations
3.
Tang, Jack Pengfei, Cole W. Peters, Reiko Yamada, et al.. (2022). Hypophosphatemia Due to Increased Effector Cell Metabolic Activity Is Associated with Neurotoxicity Symptoms in CD19-Targeted CAR T-cell Therapy. Cancer Immunology Research. 10(12). 1433–1440. 19 indexed citations
4.
Zettlitz, Kirstin A., Felix B. Salazar, Reiko Yamada, et al.. (2022). 89Zr-ImmunoPET Shows Therapeutic Efficacy of Anti-CD20-IFNα Fusion Protein in a Murine B-cell Lymphoma Model. Molecular Cancer Therapeutics. 21(4). 607–615. 3 indexed citations
5.
Yamada, Reiko, et al.. (2019). In Vivo Efficacy of Anti-CD20-Interferon-Gamma Fusion Protein Against Syngeneic B Cell Lymphoma Is Mediated By Natural Killer Cells. Blood. 134(Supplement_1). 1575–1575. 1 indexed citations
6.
Xu, Shili, Tianyuan Zhou, K. Ryan Trinh, et al.. (2019). An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1−HK2+ Multiple Myeloma. Cancer Research. 79(10). 2748–2760. 44 indexed citations
7.
Young, Patricia A., Reiko Yamada, Satiro De Oliveira, et al.. (2018). Activity of Anti-CD19 Chimeric Antigen Receptor T Cells Against B Cell Lymphoma Is Enhanced by Antibody-Targeted Interferon-Alpha. Journal of Interferon & Cytokine Research. 38(6). 239–254. 7 indexed citations
8.
9.
Yamada, Reiko. (2014). Gains in Learning Outcomes of College Students in Japan: Comparative Study between Academic Fields. 13(1). 100–118. 1 indexed citations
10.
Yamada, Reiko, et al.. (2013). Anti-CD20-Interferon-β Fusion Protein Therapy of Murine B-Cell Lymphomas. Journal of Immunotherapy. 36(5). 305–318. 28 indexed citations
11.
Timmerman, John M., John C. Byrd, David Andorsky, et al.. (2012). A Phase I Dose-Finding Trial of Recombinant Interleukin-21 and Rituximab in Relapsed and Refractory Low Grade B-cell Lymphoproliferative Disorders. Clinical Cancer Research. 18(20). 5752–5760. 53 indexed citations
12.
Andorsky, David, Reiko Yamada, Jonathan Said, et al.. (2011). Programmed Death Ligand 1 Is Expressed by Non–Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells. Clinical Cancer Research. 17(13). 4232–4244. 267 indexed citations
13.
Yamada, Reiko, et al.. (2010). Direct Growth Inhibition of Both Mouse and Human B Cell Lymphomas by CpG Oligodeoxynucleotides. Blood. 116(21). 2854–2854. 1 indexed citations
14.
Yamada, Reiko, David J. Betting, Michael Ahdoot, & John M. Timmerman. (2010). Effect of CpG oligodeoxynucleotides on the growth of aggressive human B-cell lymphomas.. Journal of Clinical Oncology. 28(15_suppl). 8076–8076. 1 indexed citations
15.
Ansell, Stephen M., Sara A. Hurvitz, Patricia Koenig, et al.. (2009). Phase I Study of Ipilimumab, an Anti–CTLA-4 Monoclonal Antibody, in Patients with Relapsed and Refractory B-Cell Non–Hodgkin Lymphoma. Clinical Cancer Research. 15(20). 6446–6453. 263 indexed citations
16.
Betting, David J., Reiko Yamada, Kamran Kafi, et al.. (2009). Intratumoral But Not Systemic Delivery of CpG Oligodeoxynucleotide Augments the Efficacy of Anti-CD20 Monoclonal Antibody Therapy Against B Cell Lymphoma. Journal of Immunotherapy. 32(6). 622–631. 36 indexed citations
17.
Merritt, Robert E., Reiko Yamada, Nabil Wasif, Ronald G. Crystal, & Robert J. Korst. (2004). Effect of inhibition of multiple steps of angiogenesis in syngeneic murine pleural mesothelioma. The Annals of Thoracic Surgery. 78(3). 1042–1051. 20 indexed citations
18.
Merritt, Robert E., Reiko Yamada, Ronald G. Crystal, & Robert J. Korst. (2004). Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy. Journal of Thoracic and Cardiovascular Surgery. 127(2). 355–364. 21 indexed citations
19.
Yamada, Reiko. (1993). The gender roles of Japanese women : an assessment of gender roles of Japanese housewives living in the United States. UMI eBooks. 1 indexed citations
20.
Yamada, Reiko, et al.. (1988). Purification and Characterization of Human PlacentalAminopeptidase A. Enzyme. 40(4). 223–230. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masaki Ito Breakdown of academic impact, for papers by Yulius Y. Setiady Breakdown of academic impact, for papers by Bianca von Scheidt Breakdown of academic impact, for papers by Mercedes Gallardo Breakdown of academic impact, for papers by Jason M. Redman Breakdown of academic impact, for papers by David Siwarski Breakdown of academic impact, for papers by Shobha Seetharam Breakdown of academic impact, for papers by Bart Steiner Breakdown of academic impact, for papers by Ming Wei Breakdown of academic impact, for papers by Mala Mani
Rankless by CCL
2026